Seventh Annual Merrill P. Spencer, M.D. Endowed Lectureship
The Merrill P. Spencer, M.D. Endowed Lectureship is presented annually at the Cerebrovascular Disease Symposium. This year, we are pleased to welcome Neal F. Kassell, M.D., a notable professor in the Department of Neurosurgery at the University of Virginia. Dr. Kassell is a member of numerous medical societies in the United States and abroad. He has served on many standing and ad hoc committees of the National Institutes of Health and in an editorial capacity for a variety of academic journals. He is currently a member of the editorial boards of Neurosurgery and Stroke.
Dr. Kassell has an active clinical practice specializing in patients with cerebrovascular disease, including aneurysms, arteriovenous malformations and benign basal tumors. His research interests focus on intracranial aneurysms, as well as computing and information technology and have resulted in more than 450 publications. We are honored that he will join us to present this distinguished lecture.
Seventh Annual Merrill P. Spencer, M.D. Endowed Lectureship
Thursday, May 17, 2012
Swedish Medical Center/Cherry Hill
Reception in Honor of Neal F. Kassell, M.D.
Welcome and Introductions
Transcranial Ultrasound Treatment Applications
The Merrill P. Spencer, M.D. Endowed Lectureship is presented as part of the two-day Annual Cerebrovascular Symposium. If you only wish to register for the one-hour Merrill P. Spencer, M.D. Endowed Lectureship on Thursday evening, click here.
To register for the two-day Sixth Annual Cerebrovascular Symposium: Practical Aspects of Stroke and Cerebrovascular Care, click on the "Register Online" button located above and to the right.
The Merrill P. Spencer, M.D. Endowed Lectureship was established in 2006 to honor the memory of Dr. Spencer who enjoyed a long and distinguished career as a physician, professor, researcher and innovator. Dr. Spencer earned an international reputation for his groundbreaking work with Doppler ultrasound technology and was a pioneer in stroke prevention. This lectureship, established by an initial gift from The Institute of Applied Physiology and Medicine, founded by Dr. Spencer in 1972, honors his belief in the importance of always searching for new answers and sharing those answers with others through continuing programs of medical education.
Accreditation with Commendation
Swedish Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA PRA Category 1 Credits™
Swedish Medical Center designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Hugh Markus, M.D.
Embolism and Stroke
Presented May 12, 2011
Dr. Hugh Markus is a Professor of Neurology at St. George's University of London. Dr. Markus was educated in Medicine at Cambridge and Oxford Universities and then carried out medical jobs in Oxford, London and Nottingham before training in neurology in London. He was senior lecturer and subsequently, reader in neurology at Kings College London before moving to the chair of neurology at St George’s in 2000.
His clinical interests are in stroke, and he is clinical lead for stroke at St George’s Hospital. He is involved in both acute stroke care and outpatient stroke clinics, and runs specialist services for patients with sub cortical vascular disease and genetic forms of stroke.
His research interests are in applying molecular genetic and imaging techniques to investigate the pathogenesis of stroke. Genetic studies are primarily trying to identify genetic causes of sporadic stroke and he is the principal investigator for the Wellcome Trust Case Control Consortium 2 Ischemic Stroke Study, which is performing a large genome-wide association study in ischemic stroke. The imaging techniques he uses are Transcranial Doppler emboli detection and MRI.
His postdoctoral thesis was on emboli detection, which involved experimental studies validating the technique and early clinical studies applying it to patients with a variety of potential embolic sources. He has carried out a number of studies showing that embolic signals predict stroke in carotid artery stenosis, and pioneered the use of the technique to evaluate anti-platelet therapies. He was also principal investigator for the CARESS study. Recently, he finished the Asymptomatic Carotid Emboli Study (ACES) which demonstrated that embolic signals predict risk in asymptomatic carotid stenosis.
The first international conference which Dr. Markus attended was a Transcranial Doppler ultrasound workshop organized by Merrill Spencer, M.D. in the early 1990s.
Michael A. De Georgia, M.D., FACP, FAHA, FCCM
Struck Down: The Collision of Stroke and World History
Presented May 13, 2010
Dr. Michael De Georgia is Director of the Reinberger Neuroscience Intensive Care Unit at University Hospitals Case Medical Center in Cleveland, Ohio. He is Professor of Neurology at Case Western Reserve University School of Medicine where he holds the Maxeen Stone and John A. Flower Endowed Chair in Neurology. Dr. De Georgia is also Director of the Center for Neurocritical Care and Co-Director of the Cerebrovascular Center of University Hospitals’ Neurological Institute.
Dr. De Georgia is an internationally recognized leader in the field of neurological intensive care, which encompasses stroke, bleeding within and around the brain, head trauma, brain swelling, and coma. He is active in research related to lowering the temperature of the brain to protect it after injury and new innovative neuromonitoring approaches in the intensive care unit (such as monitoring blood flow and oxygen levels in the brain) along with the use of “complex systems analysis” tools in the ICU. He is Director of the Case Critical Care Bioinformatics Consortium, a collaboration between physicians, engineers, computer scientists, experts in informatics, and industry focusing on integrated data acquisition, processing, and innovative visualization in the intensive care unit. From 2001 to 2007, Dr. De Georgia directed the Neurological Intensive Care Program and the Neurology-Neurosurgery Intensive Care Unit at the Cleveland Clinic. Previously, he was Director of the Neurocritical Care and University Stroke Program at the State University of New York Health Science Center in Syracuse.
Dr. De Georgia earned his medical degree with honors at the Northeastern Ohio Universities College of Medicine after completing an accelerated six-year combined B.S./M.D. program. He completed an internal medicine residency at the University of Michigan Medical Center in Ann Arbor, a neurology residency at the Tufts University-New England Medical Center in Boston and a neurocritical care fellowship at the University of Heidelberg in Germany. He is board certified in Internal Medicine, Neurology, Vascular Neurology, and Neurocritical Care and is an honorary fellow of the American College of Physicians, the American Heart Association, and the American College of Critical Care Medicine. He is listed as one of “America’s Best Doctors.”
Rune Aaslid, Ph.D.
Applied Cerebrovascular Physiology
Presented June 18, 2009
Born in Norway, Dr. Rune Aaslid received his M.S. degree in Engineering Cybernetics and Electrical Engineering, and subsequently his PhD in Cardiovascular Physiology and Neurosurgical Research. One of Dr. Aaslid’s seminal contributions to the field of cerebrovascular medicine was his development and introduction of the Transcranial Doppler Method in 1982. While teaching cardiovascular physiology in Oslo, he developed one of his first important inventions, a non-invasive blood pressure device.
He was recruited in the late 1980s to the University of Bern in Switzerland, where he became the director of Neurosurgical Research and introduced Transcranial Doppler to the neurosurgery community in Europe. He has also served as the director of Cardiovascular research at the Institute of Applies Physiology and Medicine (IAPM) in Seattle, and as an associate professor of neurological research at the University of Washington.
His professional goals are to invent, develop, introduce and propagate new noninvasive methods in clinical neurophysiology and cardiovascular medicine, promote the understanding of cerebrovascular and cardiovascular hemodynamics, improve diagnosis and monitoring routines by applying cybernetic methods and develop and introduce realistic computer simulators for teaching cerebrovascular physiology and pathology.
Daniel F. Hanley, M.D.
Advancing the Treatment of Intracranial Hemorrhage: tPA, Ultrasound and Other Neurosurgical Techniques
Presented June 19, 2008
Daniel F. Hanley, M.D., is Professor of Neurology, Neurosurgery and Anesthesiology/Critical Care Medicine at the Johns Hopkins Medical Institutions as well as Professor of Nursing at The Johns Hopkins School of Nursing. He is the founding director and led for 17 years a combined Neurology and Neurosurgery Critical Care Unit at the Johns Hopkins Medical Institutions and presently directs the Brain Injury Outcomes Division (BIOS).
As the Jeffery Harriet Legum Professor of Acute Care Neurology, his expertise and clinical practice is in the area of acute brain disorders. Dr. Hanley is a recognized expert in the areas of acute care for stroke, brain hemorrhage, cardiac arrest, coma, intracranial hypertension bacterial and viral brain infections.
Best known for establishing neurological critical care as a specialty and as an educator to physicians, Dr. Hanley has trained some of the world's top neurological leaders. He has received numerous awards, including the Alexander Humboldt Research Prize for his accomplishments in Brain Injury Research and authored/co-authored more than 200 publications. Dr. Hanley serves on numerous committees including the American Academy of Neurology and the American Neurological Association.
Dr. Hanley received his medical degree from Cornell University Medical College where he also completed his residency and fellowship. His board certification is in Internal Medicine as well as Neurology and Psychiatry.
James C. Grotta, M.D.
The Intersection of Neurology and Cardiology - What we are learning
Presented December 7, 2006
James C. Grotta, M.D., board certified neurologist, serves as chairman of the Department of Neurology at the University of Texas Medical Center at Houston. He is also the Roy M. and Phyllis Huffington Distinguished Chair and professor and director of the Stroke Program.
Dr. Grotta's research focuses on development of new therapies for acute stroke patients. With funding by the NIH, Dr. Grotta has conducted laboratory studies on the biology of brain injury and recovery in animal stroke models and is currently carrying out a series of novel pilot studies aimed at amplifying the existing benefits of intravenous TPA. He has played a leadership role in many clinical trials and orchestrated development of a collaborative network among several regional stroke centers.
Among his many awards, Dr. Grotta was the recipient of the Feinberg Award for Excellence in Clinical Stroke by the American Heart Association in 1999 and the AHA Physician of the year in 2006.
Dr. Grotta received his medical degree from the University of Virginia School of Medicine and completed his residency at the University of Colorado. He also held a stroke fellowship at Massachusetts General Hospital.
Michael Moskowitz, M.D.
From Aura to Headache: Migraine Pathophysiology 2006
Presented December 2, 2005
Michael A. Moskowitz, M.D., is Professor of Neurology at Harvard Medical School and affiliated with the Harvard-MIT Division of Health Science & Technology. His research focuses on translational mechanisms in neurological diseases, particularly stoke and migraine. His laboratory is credited with discovering the sensory innervation to the circle of Willis and naming the trigeminovascular system.
Dr. Moskowitz's laboratory connected neurogenic vasodilation and protein leakage to migraine and provided the first experimental evidence linking intrinsic brain activity to trigeminal activation and reflex autonomic vasodilation. His most recent research identified cortical spreading depression as a common target for prophylactic migraine drugs.
Among his many accomplishments, Dr. Moskowitz has published more than 425 scientific articles and received honors such as the KJ Zulch Prize from the Max-Planck Society and the Bristol-Myers Research Award in Neuroscience. He served as Basic Science Editor for Stroke, president of the International Society for Cerebral Blood Flow & Metabolism and program chair for the American Stroke Association. He is currently the President of the International Headache Society.
Dr. Moskowitz trained in internal medicine at Yale and then at Harvard-Longwood Neurology Program followed by seven years on the MIT faculty and more than 25 years at the Massachusetts General Hospital.
View Brochure (pdf)
Online registration is now closed. Walk-in registration will be available on the day of the conference.